About
Prior to founding AIX Consultancy, Andrew was a part of Mundipharma, Covance (Medaxial), Parexel (Heron), IQVIA (IMS, Cambridge Pharma) and Pfizer (Pharmacia). Andrew has over 15 years experience across industry and consulting roles including general management, business development, pricing, market access, health economics, pre-clinical research, clinical development, computer programming, real-world evidence and value communication. He has founded, grown and advised several start-ups through to acquisition by large multinational corporations. Andrew has also lived and worked in Asia, North America, and Europe, which provides him with an understanding of international health systems and cultures. Andrew has a degree in Biochemistry and Economics from Northwestern University and an Executive MBA from the University of Cambridge with a dissertation in natural language processing applied to scientific literature.
More information?
